ALEXANDRIA, Virginia—The 2025 National Home Infusion Association Annual Conference (NHIA 2025) concluded earlier this month. The conference brings together 1,600 home and alternate site infusion professionals for four days of networking, education and exhibits. This year's event saw significant growth in individuals investing to attend the event and the expo featured 150 companies displaying the latest products and services supporting the industry.
NHIA 2025 speakers and research poster authors shared a variety of perspectives on the regulatory landscape and the latest trends in patient care. NHIA President and CEO Connie Sullivan set the tone for the event, sharing trendlines and insights on the future of the infusion market and NHIA’s key initiatives. An analysis of claims data shows areas of growth, such as immune globulins—the fastest growing category in home infusion therapy—as well as areas for future advocacy efforts. For example, the decreasing number of providers working in parenteral nutrition (PN) (16% per year) and increasing cost of preparing the formula (200% over the past eight years) are the basis for the association’s commercial payer outreach and exploration of value-based care models.
In addition, Medicare Advantage (MA) plans, a growing segment of the payer mix for anti-infectives (14.5% in 2022 compared to 19% in 2024), underscore the need for revamped home infusion coverage as outlined in the newly reintroduced Preserving Patient Access to Home Infusion Act. Modeled after the commercial sector S-codes, the legislation would bundle supplies and services, which create a billable daily service, and make anti-infectives eligible for coverage whether they are in Part B or D. This would provide health information technology (HIT) services access to roughly an additional one million Medicare beneficiaries. The legislation would also ensure a five-year transition that maintains the current payment rate for nursing days to allow time for providers to obtain accreditation, provide education and implement the benefit.
NHIA is working with new data partners to update its popular trends report, which will provide a clearer understanding of how the industry has evolved since the pandemic. We look forward to publishing an updated report later this year.
Education & Training
NHIA hosted its one-of-a-kind Sterile Compounding Clinic, which featured optional hands-on training in a simulated clean room environment in an exclusive area in the NHIA Expo and an exclusive education track. Participants alternate between lab time and dedicated education led by leading experts in the area.
More than 50 education sessions covered topics including preparing nurses for home infusion, implementing AI to increase patient engagement, revenue cycle and contracting best practices and strategies, the latest in clinical management and much more.
The NHIA Expo featured its first-ever Infusion Suite Experience, which led more than 350 attendees through six stations in a simulated infusion suite on the show floor. This interactive learning opportunity asked attendees to identify deficiencies and then reviewed the applicable infusion suite standards.
Recognizing Excellence
The NHIA Innovation Award highlights the role ground-breaking products and services play in improving home infusion patient care and/or advancing operations. The 2025 Innovation Award recipient was Mobility+ by Rockfield Medical Devices, a new elastomeric lightweight, mobile, silent enteral feeding system for patients aged 2 years and older, with gastrostomy or jejunostomy feeding tube. This enteral feeding system works mechanically without the need for gravity or electricity, and is wearable, filling a gap between simple bolus/gravity systems and more complex pump systems.
The 2025 winner of the NHIF Outstanding Abstract Achievement Award is Leslie Myers, PharmD, IgCP of CSI Pharmacy for “Social Determinants of Health Impact on Participant Perception with Intravenous Immunoglobulin Therapy.” Honorable mention was awarded to Amy Braglia-Tarpey, MS, RD, CNSC from Amerita for “Home Parenteral Nutrition Diagnosis and Payer Trends: 2020-2023.”